Garratty G. Drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 1985; 2:1–8.Search in Google Scholar
Harris JW. Studies on the mechanism of a drug-induced hemolytic anemia. J Lab Clin Med 1956;47:760–75.Search in Google Scholar
Carstairs KC, Breckenridge A, Dollery CT, Worlledge SM. Incidence of a positive direct Coombs test in patients on α-methyldopa. Lancet 1966;2:133–5.10.1016/S0140-6736(66)92422-6Search in Google Scholar
Worlledge SM, Carstairs KC, Dacie JV. Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy. Lancet 1966;2:135–9.10.1016/S0140-6736(66)92423-8Search in Google Scholar
Gralnick HR, Wright LD Jr, McGinniss MH. Coombs’ positive reactions associated with sodium cephalothin therapy. JAMA 1967;199:135–6.10.1001/jama.1967.03120100087016Search in Google Scholar
Molthan L, Reidenberg MM, Eichman MF. Positive direct Coombs tests due to cephalothin. N Eng J Med 1967;277: 123–5.10.1056/NEJM1967072027703036054993Search in Google Scholar
Spath P, Garratty G, Petz L. Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration. J Immunol 1971;107: 860–9.Search in Google Scholar
Petz LD, Garratty G. Acquired immune hemolytic anemias. 1st ed. New York: Churchill Livingstone, 1980.Search in Google Scholar
Kirtland HH, Mohler DN, Horwitz DA. Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia. N Engl J Med 1980;302: 825–32.10.1056/NEJM1980041030215026244489Search in Google Scholar
Miescher P, Cooper N. The fixation of soluble antigen-antibody-complexes upon thrombocytes. Vox Sang 1960;5:138–42.Search in Google Scholar
Shulman NR. A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in autoimmunity. Ann Intern Med 1964;60:506–21.10.7326/0003-4819-60-3-50614128231Search in Google Scholar
Christie DJ, Mullen PC, Aster RH. Fab-mediated binding of drug-dependent antibodies to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 1985;75: 310–14.10.1172/JCI1116914234423871201Search in Google Scholar
Smith ME, Reid DM, Jones CE, Jordan JV, Kautz CA, Shulman NR. Binding of quinine- and quinidine-dependent drug antibodies to platelets is mediated by the Fab domain of the immunoglobulin G and is not Fc dependent. J Clin Invest 1987;79:912–17.10.1172/JCI1129014242353818954Search in Google Scholar
Jordan JV, Smith ME, Reid DM, Jones CE, Kautz CA, Shulman NR. A tolmetin-dependent antibody causing severe intravascular hemolysis binds to erythrocyte band 3 and requires only the F(ab′)2 domain to react (abstract). Blood 1985;66(Suppl):104a.Search in Google Scholar
Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost 2009;7:911–18.10.1111/j.1538-7836.2009.03360.x293518519344362Search in Google Scholar
Habibi B, Bretagne Y. Blood group antigens may be the receptors for specific drug-antibody complexes reacting with red blood cells (in French). C R Seances Acad Sci III 1983;296:693–6.Search in Google Scholar
Johnson ST, Weitekamp LA, Wilkins JL, Heim ED, MacDonald JD, Barylak EJ. Diclofenac-dependent antibody with relative e specificity causing hemolytic anemia and emphasizing the need for metabolite testing (abstract). Transfusion 1993;33(Suppl):63S.Search in Google Scholar
Shirey RS, Bartholomew J, Bell W, Pollack B, Kickler TS, Ness PM. Characterization of antibody and selection of alternative drug therapy in hydrochlorothiazide-induced immune hemolytic anemia. Transfusion 1988;28:70–2.10.1046/j.1537-2995.1988.28188127959.x3341072Search in Google Scholar
Johnson ST, Fueger JT, Gottschall JL, Aster RH. Ibuprofen-dependent antibody with Rh specificity reacting with untreated red cells in the presence of drug (abstract). Transfusion 1996; 36(Suppl):54S.Search in Google Scholar
Salama A, Mueller-Eckhardt C. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine. Blood 1986;68:1285–8.10.1182/blood.V68.6.1285.1285Search in Google Scholar
Johnson ST, Weitekamp LA, Sauer DE, Fueger JT, Aster RH. Piperacillin-dependent antibody with relative e specificity reacting with drug treated red cells and untreated red cells in the presence of drug (abstract). Transfusion 1994;34(Suppl):70S.Search in Google Scholar
Osbourne SE, Johnson ST, Weitekamp LA, Curtis BR, Aster RH. Enhanced detection of drug-dependent antibodies reacting with untreated red blood cells in the presence of drug (abstract). Transfusion 1994;34(Suppl):20S.Search in Google Scholar
Ahrens N, Genth R, Salama A. Belated diagnosis in three patients with rifampicin-induced immune haemolytic anaemia. Br J Haematol 2002;117:441–3.10.1046/j.1365-2141.2002.03416.x11972531Search in Google Scholar
Letona JML, Barbolla L, Frieyro E, Bouza E, Gilsanz F, Fernández MN. Immune haemolytic anaemia and renal failure induced by streptomycin. Br J Haematol 1977;35:561–71.10.1111/j.1365-2141.1977.tb00621.x405985Search in Google Scholar
DeCoteau J, Reis MD, Pinkerton PH, Ward J, Coovadia AS. Positive antiglobulin test in association with sulindac: involvement of the Rh factor. Vox Sang 1993;64:179–83.10.1111/j.1423-0410.1993.tb05159.x8484252Search in Google Scholar
Colluccio E, Villa MA, Villa E, et al. Immune hemolytic anemia associated with teicoplanin. Transfusion 2004;44:73–6.10.1111/j.0041-1132.2003.00599.x14692970Search in Google Scholar
Weitekamp LA, Johnson ST, Fueger JT, Clark JR, Aster RH. A fatal case of tolmetin-induced hemolytic anemia with relative e specificity (abstract). Transfusion 1991;31(Suppl):52S.Search in Google Scholar
Duran-Suarez JR, Martin-Vega C, Argelagues E, Massuet L, Ribera A, Triginer J. Red cell I antigen as immune complex receptor in drug-induced hemolytic anemias. Vox Sang 1981;41:313–15.10.1111/j.1423-0410.1981.tb01055.x7324446Search in Google Scholar
Sandvei P, Nordhagen R, Michaelsen TE, Wolthuis K. Fluorouracil (5-FU) induced acute immune haemolytic anaemia. Br J Haematol 1987;65:357–9.10.1111/j.1365-2141.1987.tb06868.x3567089Search in Google Scholar
Nordhagen R, Vik H, Wolthuis K, Bøhn HP, Urdahl P, Michaelsen TE. Immune-mediated hemolysis associated with the administration of a radiographic contrast medium. Transfusion 1991;31:843–6.10.1046/j.1537-2995.1991.31992094673.x1755090Search in Google Scholar
Salama A, Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia. Blood 1987;69:1006–10.10.1182/blood.V69.4.1006.1006Search in Google Scholar
Habibi B, Basty R, Chodez S, Prunat A. Thiopental-related immune hemolytic anemia and renal failure. Specific involvement of red-cell antigen I. N Engl J Med 1985;312: 353–5.10.1056/NEJM1985020731206063969087Search in Google Scholar
Arndt PA, Revilla J, Leger RM, Garratty G. Studies on specificity of selected drug-dependent antibodies (abstract). Transfusion 2013;53(Suppl):17A.Search in Google Scholar
Pham B-N, Gien D, Bensaad F, et al. Antibodies to co-trimoxazole (trimethoprim and/or sulfamethoxazole) related to the presence of the drug in a commercial low-ionic-strength solution. Transfusion 2012;52:844–8.10.1111/j.1537-2995.2011.03327.xSearch in Google Scholar
Sosler SD, Behzad O, Garratty G, Lee CL, Postoway N, Khomo O. Acute hemolytic anemia associated with a chlorpropamide-induced apparent auto anti-Jka. Transfusion 1984;24:206–9.10.1046/j.1537-2995.1984.24384225022.xSearch in Google Scholar
Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia, PA: Churchill Livingstone, 2004.10.1016/B978-0-443-08559-8.50012-1Search in Google Scholar
Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010;24:143–50.10.1016/j.blre.2010.06.004Search in Google Scholar
Ackroyd JF. Allergic purpura, including purpura due to foods, drugs and infections. Am J Med 1953;14:605–32.10.1016/0002-9343(53)90377-5Search in Google Scholar
Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev 1990;4:69–77.10.1016/S0887-7963(90)70249-0Search in Google Scholar
Shulman NR, Reid DM. Mechanisms of drug-induced immunologically mediated cytopenias. Transfus Med Rev 1993;7:215–29.10.1016/S0887-7963(93)70142-XSearch in Google Scholar
Aster RH. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol 1999;36(Suppl 1): 2–6.Search in Google Scholar
Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br J Haematol 1985;61:139–43.10.1111/j.1365-2141.1985.tb04069.xSearch in Google Scholar
Bougie DW, Wilker PR, Aster RH. Patients with quinine-induced immune thrombocytopenia have both “drug-dependent” and “drug-specific” antibodies. Blood 2006;108: 922–7.10.1182/blood-2006-01-009803Search in Google Scholar
Garratty G. Immune cytopenia associated with antibiotics. Transfus Med Rev 1993;7:255–67.10.1016/S0887-7963(93)70145-5Search in Google Scholar
Salama A, Göttsche B, Schleiffer T, Mueller-Eckhardt C. ‘Immune complex’ mediated intravascular hemolysis due to IgM cephalosporin-dependent antibody. Transfusion 1987;27: 460–3.10.1046/j.1537-2995.1987.27688071694.x3500531Search in Google Scholar
Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion 1991;31:176–9.10.1046/j.1537-2995.1991.31291142951.x1825363Search in Google Scholar
Leger RM, Arndt PA, Garratty G. How we investigate drug-induced immune hemolytic anemia. Immunohematology 2014;30:85–94.10.21307/immunohematology-2019-102Search in Google Scholar
Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol 2005;42:137–44.10.1053/j.seminhematol.2005.04.00416041663Search in Google Scholar
Johnson ST, Fueger JT, Gottschall JL. One center’s experience: the serology and drugs associated with drug-induced immune hemolytic anemia—a new paradigm. Transfusion 2007;47: 697–702.10.1111/j.1537-2995.2007.01173.x17381629Search in Google Scholar
Quillen K, Lane C, Hu E, Pelton S, Bateman S. Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection. Pediatr Infect Dis J 2008;27:357–8.10.1097/INF.0b013e3181629a5518316983Search in Google Scholar
Arndt PA, Leger RM, Garratty G. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia. Transfusion 2012;52:602–12.10.1111/j.1537-2995.2011.03321.x21880048Search in Google Scholar
Meyer O, Hackstein H, Hoppe B, Göbel FJ, Bein G, Salama A. Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol 1999;105:1084–5.10.1046/j.1365-2141.1999.01434.x10554824Search in Google Scholar
Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000;26:1390–4.10.1007/s00134000059811089773Search in Google Scholar
Kim S, Song KS, Kim HO, Lee HM. Ceftriaxone induced immune hemolytic anemia: detection of drug-dependent antibody by ex-vivo antigen in urine. Yonsei Med J 2002;43: 391–4.10.3349/ymj.2002.43.3.39112089751Search in Google Scholar
Arndt PA. Practical aspects of investigating drug-induced immune hemolytic anemia due to cefotetan or ceftriaxone—a case study approach. Immunohematology 2002;18:27–32.10.21307/immunohematology-2019-504Search in Google Scholar
Arndt PA, Leger RM, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion 1999;39:1239–46.10.1046/j.1537-2995.1999.39111239.xSearch in Google Scholar
Garratty G, Leger RM, Arndt PA. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Am J Obstet Gynecol 1999;181:103–4.10.1016/S0002-9378(99)70443-6Search in Google Scholar
Perkins J. Fatal drug-induced immune hemolytic anemia due to cefotetan: a case study. Asian J Transfus Sci 2008;2:20–3.10.4103/0973-6247.39507279875920041074Search in Google Scholar
Arndt P, Garratty G. Is severe immune hemolytic anemia, following a single dose of cefotetan, associated with the presence of “naturally-occurring” anti-cefotetan (abstract)? Transfusion 2001;41(Suppl):24S.Search in Google Scholar
Davenport RD, Judd WJ, Dake LR. Persistence of cefotetan on red blood cells. Transfusion 2004;44:849–52.10.1111/j.1537-2995.2004.03360.x15157250Search in Google Scholar
Viraraghavan R, Chakravarty AG, Soreth J. Cefotetan-induced haemolytic anaemia. A review of 85 cases. Adverse Drug React Toxicol Rev 2002;21:101–7.10.1007/BF0325618412140903Search in Google Scholar
Arndt PA, Garratty G. Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other cephalosporins and penicillin. Am J Clin Pathol 2002;118:256–62.10.1309/JFJE-VUKN-221T-G6EV12162687Search in Google Scholar
Arndt PA, Leger RM, Garratty G. Reactivity of “last wash” elution controls in investigation of cefotetan antibodies (abstract). Transfusion 1999;39(Suppl):47S.Search in Google Scholar
Williams ME, Thomas D, Harman CP, Mintz PD, Donowitz GR. Positive direct antiglobulin tests due to clavulanic acid. Antimicrob Agents Chemother 1985;27:125–7.10.1128/AAC.27.1.1251762173872623Search in Google Scholar
Lutz P, Dzik W. Very high incidence of a positive direct antiglobulin test (+ DAT) in patients receiving Unasyn® (abstract). Transfusion 1992;32(Suppl):23S.Search in Google Scholar
Garratty G, Arndt PA. Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells. Br J Haematol 1998;100:777–83.10.1046/j.1365-2141.1998.00615.x9531349Search in Google Scholar
Arndt P, Garratty G. Can nonspecific protein coating of RBCs lead to increased RBC destruction? Drug-treated RBCs with positive antiglobulin tests due to nonspecific uptake give positive monocyte monolayer assays (abstract). Transfusion 2000;40(Suppl):29S.Search in Google Scholar
Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004;44:1273–81.10.1111/j.1537-2995.2004.03427.x15318848Search in Google Scholar
Arndt PA, Leger RM, Garratty G. Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells. Vox Sang 2003;85:53.10.1046/j.1423-0410.2003.00323.x12823734Search in Google Scholar
Broadberry RE, Farren TW, Bevin SV, et al. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient’s red cells. Transfus Med 2004;14:53–7.10.1111/j.0958-7578.2004.00481.x15043594Search in Google Scholar
Arndt PA, Garratty G, Hill J, Kasper M, Chandrasekaran V. Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the ‘immune complex’ method. Vox Sang 2002;83:273–8.10.1046/j.1423-0410.2002.00188.x12366773Search in Google Scholar
Leger RM, Arndt PA, Garratty G. Serological studies of piperacillin antibodies. Transfusion 2008;48:2429–34.10.1111/j.1537-2995.2008.01852.x18657075Search in Google Scholar
Leger RM, Garratty G. Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors. Transfusion 2011;51:1740–4.10.1111/j.1537-2995.2010.03040.x21303372Search in Google Scholar
Arndt PA, Leger RM, Garratty G. IgM agglutinins to meropenem, a beta-lactam antibiotic, are found in plasma of healthy blood donors and random patients (abstract). Transfusion 2012;52(Suppl):26A.Search in Google Scholar
Mayer B, Yürek S, Salama A. Piperacillin-induced immune hemolysis: new cases and a concise review of the literature. Transfusion 2010;50:1135–8.10.1111/j.1537-2995.2009.02544.x20051057Search in Google Scholar
Arndt PA, Leger RM, Garratty G. Serological characteristics of anti-piperacillin in seventeen patients with drug-induced immune hemolytic anemia (abstract). Transfusion 2010;50(Suppl):37A.Search in Google Scholar
Johnson ST. Warm autoantibody or drug dependent antibody? That is the question! Immunohematology 2007;23:161–4.10.21307/immunohematology-2019-335Search in Google Scholar
